China Lung Cancer Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, fatigue and chest pain.

    This report elaborates on the current development of the Lung Cancer industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • ELI Lilly and Company

    • AbbVie

    • Bristol-Myers Squibb

    • Pharmacyclics

    • Ventana

    • Sanofi

    • Novartis

    • Merck&Co

    • F Hoffmann-La Roche AG

    • Daiichi Sankyo co Ltd

    • PFIZER INC

    • Arqule Inc

    • Boehringer

    • Celgene

    By Type:

    • Laser therapy

    • Surgery

    • Photodynamic therapy (PDT)

    • Radiotherapy

    • Chemotherapy

    By Application:

    • Cancer Research Centers

    • Hospitals & Clinics

    • Laboratories

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Lung Cancer Market Overview 2018-2029

    • 1.1 China Lung Cancer Industry Development Overview

    • 1.2 China Lung Cancer Industry Development History

    • 1.3 China Lung Cancer Industry Market Size (2018-2029)

    • 1.4 China Lung Cancer Market Analysis by Type from Production Side

      • 1.4.1 China Lung Cancer Production Volume, Production Value and Growth Rate of Laser therapy (2018-2029)

      • 1.4.2 China Lung Cancer Production Volume, Production Value and Growth Rate of Surgery (2018-2029)

      • 1.4.3 China Lung Cancer Production Volume, Production Value and Growth Rate of Photodynamic therapy (PDT) (2018-2029)

      • 1.4.4 China Lung Cancer Production Volume, Production Value and Growth Rate of Radiotherapy (2018-2029)

      • 1.4.5 China Lung Cancer Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

    • 1.5 China Lung Cancer Market Analysis by Application from Consumption End

      • 1.5.1 China Lung Cancer Sales Volume, Sales Value and Growth Rate of Cancer Research Centers (2018-2029)

      • 1.5.2 China Lung Cancer Sales Volume, Sales Value and Growth Rate of Hospitals & Clinics (2018-2029)

      • 1.5.3 China Lung Cancer Sales Volume, Sales Value and Growth Rate of Laboratories (2018-2029)

    • 1.6 China Lung Cancer Market Analysis by Region

      • 1.6.1 North China Lung Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Lung Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Lung Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Lung Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Lung Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Lung Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Lung Cancer Market Size and Growth Rate from 2018-2029

    Chapter 2 China Lung Cancer Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Lung Cancer Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Lung Cancer Market Status and Competition Analysis in 2023

      • 2.2.3 China Lung Cancer Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Lung Cancer Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Lung Cancer Industry Development

    Chapter 3 Lung CancerIndustry Chain Analysis

    • 3.1 Lung Cancer Industry Chain

    • 3.2 Lung Cancer Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Lung Cancer Market

    • 3.3 Lung Cancer Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Lung Cancer Market

    Chapter 4 China Lung Cancer Market, by Type

    • 4.1 China Lung Cancer Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Lung Cancer Total Production Volume and Growth Rate from Production Side

    • 4.5 China Lung Cancer Production Volume and Growth Rate, by Type

      • 4.5.1 China Lung Cancer Production Volume and Growth Rate of Laser therapy

      • 4.5.2 China Lung Cancer Production Volume and Growth Rate of Surgery

      • 4.5.3 China Lung Cancer Production Volume and Growth Rate of Photodynamic therapy (PDT)

      • 4.5.4 China Lung Cancer Production Volume and Growth Rate of Radiotherapy

      • 4.5.5 China Lung Cancer Production Volume and Growth Rate of Chemotherapy

    Chapter 5 China Lung Cancer Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Lung Cancer Total Market Size and Growth Rate from Consumption End

    • 5.5 China Lung Cancer Market Size and Growth Rate, by Application

      • 5.5.1 China Lung Cancer Market Size and Growth Rate of Cancer Research Centers

      • 5.5.2 China Lung Cancer Market Size and Growth Rate of Hospitals & Clinics

      • 5.5.3 China Lung Cancer Market Size and Growth Rate of Laboratories

    Chapter 6 China Lung Cancer Market, by Region

    • 6.1 China Lung Cancer Production Volume and Production Value, by Region

    • 6.2 China Lung Cancer Sales Volume and Sales Value, by Region

    Chapter 7 North China Lung Cancer Market Analysis

    • 7.1 North China Lung Cancer Market, by Type

    • 7.2 North China Lung Cancer Market, by Application

    Chapter 8 Central China Lung Cancer Market Analysis

    • 8.1 Central China Lung Cancer Market, by Type

    • 8.2 Central China Lung Cancer Market, by Application

    Chapter 9 South China Lung Cancer Market Analysis

    • 9.1 South China Lung Cancer Market, by Type

    • 9.2 South China Lung Cancer Market, by Application

    Chapter 10 East China Lung Cancer Market Analysis

    • 10.1 East China Lung Cancer Market, by Type

    • 10.2 East China Lung Cancer Market, by Application

    Chapter 11 Northeast China Lung Cancer Market Analysis

    • 11.1 Northeast China Lung Cancer Market, by Type

    • 11.2 Northeast China Lung Cancer Market, by Application

    Chapter 12 Southwest China Lung Cancer Market Analysis

    • 12.1 Southwest China Lung Cancer Market, by Type

    • 12.2 Southwest China Lung Cancer Market, by Application

    Chapter 13 Northwest China Lung Cancer Market Analysis

    • 13.1 Northwest China Lung Cancer Market, by Type

    • 13.2 Northwest China Lung Cancer Market, by Application

    Chapter 14 Company Profiles

      • 14.1 ELI Lilly and Company

        • 14.1.1 ELI Lilly and Company Company Profile

        • 14.1.2 ELI Lilly and Company Lung Cancer Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AbbVie

        • 14.2.1 AbbVie Company Profile

        • 14.2.2 AbbVie Lung Cancer Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Bristol-Myers Squibb

        • 14.3.1 Bristol-Myers Squibb Company Profile

        • 14.3.2 Bristol-Myers Squibb Lung Cancer Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Pharmacyclics

        • 14.4.1 Pharmacyclics Company Profile

        • 14.4.2 Pharmacyclics Lung Cancer Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Ventana

        • 14.5.1 Ventana Company Profile

        • 14.5.2 Ventana Lung Cancer Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sanofi

        • 14.6.1 Sanofi Company Profile

        • 14.6.2 Sanofi Lung Cancer Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novartis

        • 14.7.1 Novartis Company Profile

        • 14.7.2 Novartis Lung Cancer Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merck&Co

        • 14.8.1 Merck&Co Company Profile

        • 14.8.2 Merck&Co Lung Cancer Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 F Hoffmann-La Roche AG

        • 14.9.1 F Hoffmann-La Roche AG Company Profile

        • 14.9.2 F Hoffmann-La Roche AG Lung Cancer Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Daiichi Sankyo co Ltd

        • 14.10.1 Daiichi Sankyo co Ltd Company Profile

        • 14.10.2 Daiichi Sankyo co Ltd Lung Cancer Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 PFIZER INC

        • 14.11.1 PFIZER INC Company Profile

        • 14.11.2 PFIZER INC Lung Cancer Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Arqule Inc

        • 14.12.1 Arqule Inc Company Profile

        • 14.12.2 Arqule Inc Lung Cancer Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Boehringer

        • 14.13.1 Boehringer Company Profile

        • 14.13.2 Boehringer Lung Cancer Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Celgene

        • 14.14.1 Celgene Company Profile

        • 14.14.2 Celgene Lung Cancer Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Lung Cancer Industry Research Conclusions

    • 15.2 Lung Cancer Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Lung Cancer Industry Market Size (2018-2029)

    • Figure China Lung Cancer Production Volume, Production Value and Growth Rate of Laser therapy (2018-2029)

    • Figure China Lung Cancer Production Volume, Production Value and Growth Rate of Surgery (2018-2029)

    • Figure China Lung Cancer Production Volume, Production Value and Growth Rate of Photodynamic therapy (PDT) (2018-2029)

    • Figure China Lung Cancer Production Volume, Production Value and Growth Rate of Radiotherapy (2018-2029)

    • Figure China Lung Cancer Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

    • Figure China Lung Cancer Sales Volume, Sales Value and Growth Rate of Cancer Research Centers (2018-2029)

    • Figure China Lung Cancer Sales Volume, Sales Value and Growth Rate of Hospitals & Clinics (2018-2029)

    • Figure China Lung Cancer Sales Volume, Sales Value and Growth Rate of Laboratories (2018-2029)

    • Figure North China Lung Cancer Market Size and Growth Rate from 2018-2029

    • Figure Central China Lung Cancer Market Size and Growth Rate from 2018-2029

    • Figure South China Lung Cancer Market Size and Growth Rate from 2018-2029

    • Figure East China Lung Cancer Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Lung Cancer Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Lung Cancer Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Lung Cancer Market Size and Growth Rate from 2018-2029

    • Figure Lung Cancer Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Lung Cancer Market Share by Type in 2018

    • Figure China Lung Cancer Market Share by Type in 2023

    • Figure China Lung Cancer Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Lung Cancer Production Volume and Growth Rate of Laser therapy (2018-2023)

    • Figure China Lung Cancer Production Volume and Growth Rate of Surgery (2018-2023)

    • Figure China Lung Cancer Production Volume and Growth Rate of Photodynamic therapy (PDT) (2018-2023)

    • Figure China Lung Cancer Production Volume and Growth Rate of Radiotherapy (2018-2023)

    • Figure China Lung Cancer Production Volume and Growth Rate of Chemotherapy (2018-2023)

    • Figure China Lung Cancer Market Share by Application in 2018

    • Figure China Lung Cancer Market Share by Application in 2023

    • Figure China Lung Cancer Total Market Size and Growth Rate from Consumption End

    • Figure China Lung Cancer Market Size and Growth Rate of Cancer Research Centers (2018-2023)

    • Figure China Lung Cancer Market Size and Growth Rate of Hospitals & Clinics (2018-2023)

    • Figure China Lung Cancer Market Size and Growth Rate of Laboratories (2018-2023)

    • Table China Lung Cancer Production Volume by Region (2018-2023)

    • Table China Lung Cancer Production Volume Share by Region (2018-2023)

    • Figure China Lung Cancer Production Volume Share by Region (2018-2023)

    • Table China Lung Cancer Production Value by Region (2018-2023)

    • Table China Lung Cancer Production Value Share by Region (2018-2023)

    • Figure China Lung Cancer Production Value Share by Region (2018-2023)

    • Table China Lung Cancer Sales Volume by Region (2018-2023)

    • Table China Lung Cancer Sales Volume Share by Region (2018-2023)

    • Figure China Lung Cancer Sales Volume Share by Region (2018-2023)

    • Table China Lung Cancer Sales Value by Region (2018-2023)

    • Table China Lung Cancer Sales Value Share by Region (2018-2023)

    • Figure China Lung Cancer Sales Value Share by Region (2018-2023)

    • Table North China Lung Cancer Production Volume by Type (2018-2023)

    • Table North China Lung Cancer Production Volume Share by Type (2018-2023)

    • Figure North China Lung Cancer Production Volume Share by Type (2018-2023)

    • Table North China Lung Cancer Sales Volume by Application (2018-2023)

    • Table North China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Figure North China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Table Central China Lung Cancer Production Volume by Type (2018-2023)

    • Table Central China Lung Cancer Production Volume Share by Type (2018-2023)

    • Figure Central China Lung Cancer Production Volume Share by Type (2018-2023)

    • Table Central China Lung Cancer Sales Volume by Application (2018-2023)

    • Table Central China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Figure Central China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Table South China Lung Cancer Production Volume by Type (2018-2023)

    • Table South China Lung Cancer Production Volume Share by Type (2018-2023)

    • Figure South China Lung Cancer Production Volume Share by Type (2018-2023)

    • Table South China Lung Cancer Sales Volume by Application (2018-2023)

    • Table South China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Figure South China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Table East China Lung Cancer Production Volume by Type (2018-2023)

    • Table East China Lung Cancer Production Volume Share by Type (2018-2023)

    • Figure East China Lung Cancer Production Volume Share by Type (2018-2023)

    • Table East China Lung Cancer Sales Volume by Application (2018-2023)

    • Table East China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Figure East China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Table Northeast China Lung Cancer Production Volume by Type (2018-2023)

    • Table Northeast China Lung Cancer Production Volume Share by Type (2018-2023)

    • Figure Northeast China Lung Cancer Production Volume Share by Type (2018-2023)

    • Table Northeast China Lung Cancer Sales Volume by Application (2018-2023)

    • Table Northeast China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Table Southwest China Lung Cancer Production Volume by Type (2018-2023)

    • Table Southwest China Lung Cancer Production Volume Share by Type (2018-2023)

    • Figure Southwest China Lung Cancer Production Volume Share by Type (2018-2023)

    • Table Southwest China Lung Cancer Sales Volume by Application (2018-2023)

    • Table Southwest China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Table Northwest China Lung Cancer Production Volume by Type (2018-2023)

    • Table Northwest China Lung Cancer Production Volume Share by Type (2018-2023)

    • Figure Northwest China Lung Cancer Production Volume Share by Type (2018-2023)

    • Table Northwest China Lung Cancer Sales Volume by Application (2018-2023)

    • Table Northwest China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Lung Cancer Sales Volume Share by Application (2018-2023)

    • Table ELI Lilly and Company Company Profile

    • Table ELI Lilly and Company Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Pharmacyclics Company Profile

    • Table Pharmacyclics Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Ventana Company Profile

    • Table Ventana Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Merck&Co Company Profile

    • Table Merck&Co Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche AG Company Profile

    • Table F Hoffmann-La Roche AG Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo co Ltd Company Profile

    • Table Daiichi Sankyo co Ltd Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table PFIZER INC Company Profile

    • Table PFIZER INC Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Arqule Inc Company Profile

    • Table Arqule Inc Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Boehringer Company Profile

    • Table Boehringer Lung Cancer Revenue, Price and Gross (2018-2023)

    • Table Celgene Company Profile

    • Table Celgene Lung Cancer Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.